Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Effects of biologic therapy on novel indices of lung inhomogeneity in patients with severe type-2 high asthma

Alamoudi A. et al, (2025), BMJ Open Respiratory Research, 12, e002721 - e002721

Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics.

Bourdin A. et al, (2024), The journal of allergy and clinical immunology. In practice, 12, 809 - 823

The Lancet COPD Commission: broader questions remain

Petousi N. et al, (2023), The Lancet, 401, 1569 - 1570

Toward a Predict and Prevent Approach in Obstructive Airway Diseases.

Couillard S. et al, (2023), J Allergy Clin Immunol Pract

Editorial: Physiological phenotyping in respiratory diseases: New approaches.

King GG. et al, (2023), Frontiers in physiology, 14

Altered lung physiology in two cohorts after COVID-19 infection as assessed by computed cardiopulmonography

Magor-Elliott SRM. et al, (2022), Journal of Applied Physiology, 133, 1175 - 1191

Load More